Package 16729-391-30

Brand: gemcitabine

Generic: gemcitabine
NDC Package

Package Facts

Identity

Package NDC 16729-391-30
Digits Only 1672939130
Product NDC 16729-391
Product ID 16729-391_22df64f5-26e2-6cf4-e063-6394a90aecf0
Description

2 mL in 1 VIAL, MULTI-DOSE (16729-391-30)

Marketing

Marketing Status
Marketed Since 2018-01-24
Brand gemcitabine
Generic gemcitabine
Sample Package No

Linked Drug Pages (1)

GEMCITABINE ndc-match (0.95)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["INTRAVENOUS"], "spl_id": "22df64f5-26e2-6cf4-e063-6394a90aecf0", "openfda": {"upc": ["0316729426053", "0316729419031", "0316729423335", "0316729391306"], "unii": ["U347PV74IL"], "rxcui": ["1998783"], "spl_set_id": ["5a335d36-408b-478f-9563-4bc140b69bb6"], "manufacturer_name": ["Accord Healthcare Inc."], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "2 mL in 1 VIAL, MULTI-DOSE (16729-391-30)", "package_ndc": "16729-391-30", "marketing_start_date": "20180124"}], "brand_name": "GEMCITABINE", "product_id": "16729-391_22df64f5-26e2-6cf4-e063-6394a90aecf0", "dosage_form": "INJECTION, SOLUTION", "pharm_class": ["Nucleic Acid Synthesis Inhibitors [MoA]", "Nucleoside Metabolic Inhibitor [EPC]"], "product_ndc": "16729-391", "generic_name": "GEMCITABINE", "labeler_name": "Accord Healthcare Inc.", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "GEMCITABINE", "active_ingredients": [{"name": "GEMCITABINE HYDROCHLORIDE", "strength": "100 mg/mL"}], "application_number": "NDA209604", "marketing_category": "NDA", "marketing_start_date": "20180124", "listing_expiration_date": "20261231"}